These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 7589715)

  • 1. Overexpression of p53 and MDM2 proteins in cervical neoplasia.
    Lukás Z; Vojtĕsek B; Anton M; Picksley SM; Kubálek V
    Folia Biol (Praha); 1995; 41(3-4):197-9. PubMed ID: 7589715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia.
    Dellas A; Schultheiss E; Almendral AC; Gudat F; Oberholzer M; Feichter G; Moch H; Torhorst J
    Int J Cancer; 1997 Aug; 74(4):421-5. PubMed ID: 9291432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 and MDM2 expression in oral squamous cell carcinoma.
    Matsumura T; Yoshihama Y; Kimura T; Shintani S; Alcalde RE
    Oncology; 1996; 53(4):308-12. PubMed ID: 8692535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of mdm2 and p21WAF1 in invasive cervical cancer: correlation with p53 protein and high risk HPV infection.
    Troncone G; Martinez JC; Palombini L; De Rosa G; Mugica C; Rodriguez JA; Zeppa P; Di Vizio D; Lucariello A; Piris MA
    J Clin Pathol; 1998 Oct; 51(10):754-60. PubMed ID: 10023338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In squamous cell carcinoma of the vulva, overexpression of p53 is a late event and neither p53 nor mdm2 expression is a useful marker to predict lymph node metastases.
    Emanuels AG; Koudstaal J; Burger MP; Hollema H
    Br J Cancer; 1999 Apr; 80(1-2):38-43. PubMed ID: 10389975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions.
    Dimitrakakis C; Kymionis G; Diakomanolis E; Papaspyrou I; Rodolakis A; Arzimanoglou I; Leandros E; Michalas S
    Gynecol Oncol; 2000 Apr; 77(1):129-36. PubMed ID: 10739702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prognostic significance of Mdm2/p53 co-overexpression in soft tissue sarcomas of the extremities.
    Würl P; Meye A; Schmidt H; Lautenschläger C; Kalthoff H; Rath FW; Taubert H
    Oncogene; 1998 Mar; 16(9):1183-5. PubMed ID: 9528860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of p53 and MDM2 protein expression in head and neck carcinogenesis.
    Girod SC; Cesarz D; Fischer U; Krueger GR
    Anticancer Res; 1995; 15(4):1453-7. PubMed ID: 7654034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [TP53 gene aberrations in chondromatous neoplasms: correlation with immunohistochemical p53 accumulation and MDM2 expression].
    Blasenbreu S; Baretton GB; Bender C; Haas CJ; Diebold J; Löhrs U
    Verh Dtsch Ges Pathol; 1998; 82():284-9. PubMed ID: 10095448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective compartmentalization of different mdm2 proteins within the nucleus.
    Maxwell SA
    Anticancer Res; 1994; 14(6B):2541-7. PubMed ID: 7872679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strong correlation of basement membrane degradation with p53 inactivation and/or MDM2 overexpression in superficial urothelial carcinomas.
    Ozdemir E; Kakehi Y; Okuno H; Habuchi T; Okada Y; Yoshida O
    J Urol; 1997 Jul; 158(1):206-11. PubMed ID: 9186361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 and MDM2 protein expression in squamous cell carcinoma and neighboring dysplasia from the upper aerodigestive tract.
    Ambrosch P; Ruschenburg I
    Anticancer Res; 2000; 20(5A):3151-5. PubMed ID: 11062736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1, p53, mdm2, and Ki67 protein expression in preneoplastic lesions of the larynx.
    Capaccio P; Carboni N; Pignataro L; Scotti A; Ottaviani F; Pruneri G
    J Chemother; 1997 Apr; 9(2):113-4. PubMed ID: 9176749
    [No Abstract]   [Full Text] [Related]  

  • 14. MDM2 expression in areca quid chewing-associated oral squamous cell carcinomas in Taiwan.
    Huang JS; Ho TJ; Chiang CP; Kok SH; Kuo YS; Kuo MY
    J Oral Pathol Med; 2001 Jan; 30(1):53-8. PubMed ID: 11140901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue.
    Porter PL; Gown AM; Kramp SG; Coltrera MD
    Am J Pathol; 1992 Jan; 140(1):145-53. PubMed ID: 1731521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the immunoreactivity of three anti-p53 antibodies and estimation of the relations between p53 status and MDM2 protein expression in ovarian carcinomas.
    Harlozińska A; Bar J; Montenarh M
    Anticancer Res; 2000; 20(2A):1049-56. PubMed ID: 10810396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of functional inactivation of p53 from MDM2 overexpression in hepatocarcinogenesis].
    Luo YL; Cheng RX; Feng DY
    Hunan Yi Ke Da Xue Xue Bao; 2001 Feb; 26(1):13-6. PubMed ID: 12536604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of MDM2, p53, and NCAM proteins in human radiation-induced skin ulcers.
    Zhao P; Wang D; Gao Y; Yang Z; Li X
    J Environ Pathol Toxicol Oncol; 1998; 17(2):125-7. PubMed ID: 9546748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of p53, mdm2, and bcl-2 proteins in renal cell carcinoma.
    Uchida T; Gao JP; Wang C; Jiang SX; Muramoto M; Satoh T; Minei S; Shimura S; Irie A; Kameya T; Baba S
    Urology; 2002 Apr; 59(4):615-20. PubMed ID: 11927338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of Mdm2 and p53 in penile verrucous carcinoma.
    Ouban A; Dellis J; Salup R; Morgan M
    Ann Clin Lab Sci; 2003; 33(1):101-6. PubMed ID: 12661905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.